464
Views
31
CrossRef citations to date
0
Altmetric
Research Article

Genetic defects in the development and function of the anterior pituitary gland

, &
Pages 179-191 | Published online: 08 Jul 2009

References

  • Ikeda H, Suzuki J, Sasano N, Niizuma H. The development and morphogenesis of the human pituitary gland. Anat Embryo! (Berl) 1988; 178: 327–36.
  • Japon MA, Rubinstein M, Low MJ. In situ hybridizaticn analysis of anterior pituitary hormone gene expression during fetal mouse development. J His tochem Cytochem 1994; 42: 1117–25.
  • Burrows HI, Douglas KR, Seasholtz AF, Camper SA. Genealogy of the anterior pituitary gland: tracing a family tree. Trends Endocrinol Metab 1999; 10: 343–52.
  • Dasen JS, Rosenfeld MG. Signaling and transcriptional mechanisms in pituitary development. Annu Rev Neurosci 2001; 24: 327–55.
  • Cushman LJ, Camper SA. Molecular basis of pituitary dysfunction in mouse and man. Mamm Genome 2001; 12: 485–94.
  • Sloop KW, Parker GE, Rhodes SJ. Transcriptional regula-tion in mammalian pituitary development and disease. Curr Genet 2001; 2: 379–98.
  • Thomas PQ, Dattani MT, Brickman J, McNay D, Warne G, Zacharin M, et al. Heterozygous HESXI mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Hum Mol Genet 2001; 10: 39–45.
  • Dattani MT, Martinez-Barbera J-P, Thomas PQ, Brick-man JM, Gupta R, Mártensson I-L, et al. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 1998; 19: 125–33.
  • Brickman JM, Clements M, Tyrell R, McNay D, Woods K, Warner J, et al. Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders. Development 2001; 128: 5189–99.
  • Semina EV, Reiter R, Leysens NJ, Alward WL, Small KW, Datson NA, et al. Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nat Genet 1996; 14: 392–9.
  • Kulak SC, Kozlowski K, Semina EV, Pearce WG, Walter MA. Mutation in the RIEGI gene in patients with iridogo-niodysgenesis syndrome. Hum Mol Genet 1998; 7: 1113–7.
  • Doward W, Perveen R, Lloyd IC, Ridgway AE, Wilson L, Black GC. A mutation in the RIEG1 gene associated with Peter's anomaly. J Med Genet 1999; 36: 152–5.
  • Alward WLM, Semina EV, Kalenak JW, Héon E, Sheth BP, Stone EM, et al. Autosomal dominant iris hypoplasia is caused by a mutation in the Rieger syndrome (RIEG/PITX2) gene. Am J Ophthalmol 1998; 125: 98–100.
  • Saadi I, Semina EV, Amendt BA, Harris DJ, Murphy KP, Murray JC, et al. Identification of a dominant negative homeodomain mutation in Rieger Syndrome. J Biol Chem 2001; 276: 23034–41.
  • Netchine I, Sobrier ML, Krude H, Schnabel D, Maghnie M, Marcos E, et al. Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone defi-ciency. Nat Genet 2000; 25: 182–6.
  • Machinis K, Pantel J, Netchine I, Leger J, Camand OJA, Sobrier M-L, et al. Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. Am J Hum Genet 2001; 69: 961–8.
  • Agarwal G, Bhatia V, Cook S, Thomas PQ. Adrenocorti-cotropin deficiciency in combined pituitary hormone defi-ciency patients homozygous for a novel PROP1 deletion. J Clin Endocrinol Metab 2000; 85: 4556–61.
  • Fofanova 0, Takamura N, Kinoshita E, Parks J, Brown M, Peterkova V, et al. Compound heterozygous deletion of the PROP1 gene in children with combined pituitary hormone deficiency. J Clin Endocrinol Metab 1998; 83: 2601–4.
  • Krzisnik C, Kolacio Z, Battelino T, Brown M, Parks JS, Laron Z. The "little people" of the island of Krk - revisited. Etiology of hypopituitarian revealed. Journal of Endocrine Genetics 1999; 1: 9–19.
  • Duquesnoy P, Roy A, Dastot F, Ghali I, Teinturier C, Netchine I, et al. Human Prop1: cloning, mapping, genomic structure. FEBS Letters 1998; 437: 216–20.
  • Vallette-Kasic S, Barlier A, Teinturier C, Diaz A, Mana-vela M, Berthezene F, et al. PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. J Clin Endocrinol Metab 2001; 86: 4529–35.
  • Osorio MG, Kopp P, Marui S, Latronico AC, Mendonca BB, Arnhold IJ. Combined pituitary hormone deficiency caused by a novel mutation of a highly conserved residue (F88S) in the homeodomain of PROP1. J Clin Endocrinol Metab 2000; 85: 2779–85.
  • Vieira TC, Silva M, Cerutti J, Borges M, Brunner E, Abucham J. A novel mutation Arg99Gln in the hot spot region of Prop1 gene causing familial combined pituitary hormone deficiency. In 82nd Annual Meeting of the Endo-crine Society, Toronto, Canada. ENDO 2000; 538.
  • Wu W, Cogan JD, Pfäffle RW, Dasen JS, Frisch H, O'Connell SM, et al. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 1998; 18: 147–9.
  • Fofanova 0, Takamura N, Kinoshita E, Yoshimoto M, Tsuji Y, Peterkova V, et al. Rarity of Pit1 involvement in children from Russia with combined pituitary hormone deficiency. Am J Hum Genet 1998; 77: 360–5.
  • Ohta K, Nobukuiri Y, Mitsubuchi H, Fujimoto S, Mat-suo N, Inagaki H, et al. Mutations in the PIT1 gene in children with combined pituitary hormone deficiency. Bio-chem Biophys Res Commun 1992; 189: 851–5.
  • Pelligrini-Bouiller I, Belicar P, Barlier A, Gunz G, Charvet J, Jaquet P, et al. A new mutation of the gene encoding the transcription factor Pit1 is responsible for combined pituitary hormone deficiency. J Clin Endocrinol Metab 1996; 81: 2790–6.
  • Pfäffle RW, DiMattia GE, Parks JS, Brown MR, Wit JM, Jansen M, et al. Mutation of the POU-specific domain of Pit1 and hypopituitarian without pituitary hypoplasia. Science 1992; 257: 1118–21.
  • Tatsumi K, Miyai K, Notomi T, Kaibe K, Amino N, Mizuno Y, et al. Cretinism with combined hormone deficiency caused by a mutation in the Pit1 gene. Nat Genet 1992; 1: 56–8.
  • Brown M, Parks J, Adess M, Rich B, Rosenthal I, Voss T, et al. Central hypothyroidism reveals compound heterozy-gous mutations in the Pit1 gene. Horm Res 1998; 49: 98–102.
  • Hendricks-Stegeman BI, Augustijn KD, Bakker B, Holthuizen P, Van der Vliet PC, Jansen M. Combined pituitary hormone deficiency caused by compound hetero-zygosity for two novel mutations in the POU domain of the PIT1/POU1F1 gene. J Clin Endocrinol Metab 2001; 86: 1545–50.
  • Cohen LE, Zanger K, Brue T, Wondisford FE, Radovick S. Defective retinoic acid regulation of the Pit-1 gene enhancer: a novel mechanism of combined pituitary hormone defi-ciency. Mol Endocrinol 1999; 13: 476–84.
  • Pernasetti F, Milner R, al Ashwal A, Zegher F, Chavez V, Muller M, et al. Pro239Ser: a novel recessive mutation of the Pit1 gene in seven middle eastern children with growth hormone, prolactin, and thyrotropin deficiency. J Clin Endocrinol Metab 1998; 83: 2079–83.
  • Irie Y, Tatsumi K, Ogawa M, Kamijo T, Preeyasombat C, Suprasongsin C, et al. A novel E250X mutation of the PITI gene in a patient with combined pituitary hormone defi-ciency. Endocr J 1995; 42: 351–4.
  • Radovick S, Nations M, Du Y, Berg LA, Weintraub BD, Wondisford FE. A mutation in the POU-homeodomain of Pit1 responsible for combined pituitaty hormone deficiency. Science 1992; 257: 1115–7.
  • Blankenstein 0, Muhlenberg R, Kim C, Wuller S, Pfaffie R, Heimann G. A new C-terminal located mutation (V272ter) in the PIT-I gene manifesting with severe con-genital hypothyroidism: possible functionality of the PIT-1 C-terminus. Horm Res 2001; 56: 81–6.
  • Achennann IC, Ito M, Ito M, Hindmarsh PC, Jameson Li. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet 1999; 22: 125–6.
  • Biason-Lauber A, Schoenle EJ. Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF1) and adrenal insufficiency. Am J Hum Genet 2000; 67: 1563–8.
  • Lamolet B, Pulichino A-M, Lamonerie T, Gauthier Y, Brue T, Enjalbert A, et al. Pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 2001; 104: 849–59.
  • OMIM, Online Mendelian Inheritance in Man (http:// www.ncbi.nlm.nih.goVentrez/query.fcgi?db=0MIM).
  • Procter AM, Phillips III IA, Cooper DN. The molecular genetics of growth hormone deficiency. Hum Genet 1998; 103: 255–72.
  • Dasen IS, Martinez-Barbera JP, Herman TS, O'Connell S, Olson L, Ju BG, et al. Temporal regulation of a paired-like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis. Genes Dev 2001; 15: 3193–207.
  • Martinez-Barbera JP, Rodriguez TA, Beddington RS. The homeobox gene Hesx1 is required in the anterior neural ectoderm for normal forebrain formation. Dev Biol 2000; 223: 422–30.
  • Gage PI Suh H, Camper SA. Dosage requirement of Pitx2 for development of multiple organs. Development 1999; 126: 4643–51.
  • Kitamura K, Miura H, Miyagawa-Tomit a S, Yanazawa M, Katoh-Fukui Y, Suzuki R, et al. Mouse Pitx2 deficiency leads to anomalies of the ventral body wall, heart, extra- and periocular mesoderm and right pulmonary isomerism. Development 1999; 126: 5749–58.
  • Lu MF, Pressman C, Dyer R, Johnson RL, Martin JF. Function of Rieger syndrome gene in left-right asymmetry and craniofacial development. Nature 1999; 401: 276–8.
  • Lin CR, Kioussi C, O'Connell S, Briata P, Szeto D, Liu F, et al. Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis. Nature 1999; 401: 279–82.
  • Kioussi C, Carriere C, Rosenfeld MG. A model for the development of the hypothalamic-pituitaty axis: transcribing the hypophysis. Mech Dev 1999; 81: 23–35.
  • Sadeghi-Nejad A, Senior, B. Autosomal dominant transmis-sion of isolated growth hormone deficiency in iris-dental dysplasia (Rieger's syndrome). J Pediatr 1974; 85: 644–8.
  • Sheng HZ, Zhadanov AB, Mosinger BJ, Fujii T, Bertuzzi S, Grinberg A, et al. Specification of pituitary cell lineages by the LIM homeobox gene Lhx3. Science 1996; 272: 1004–7.
  • Sheng H, Moriyama K, Yamashita T, Li H, Potter S, Mahon K, et al. Multistep control of pituitary organogen-esis. Science 1997; 278: 1809–12.
  • Sloop KW, Dwyer C, Rhodes Si. An isoform-specific inhibitcny domain regulates the LHX3 LIM homeodomain factor holoprotein and the production of a functional alternate translaticn form. J Biol Chem 2001; 276: 36311–9.
  • Sloop KW, Parker GE, Hanna KR, Wright HA, Rhodes Si. LHX3 transcripticu factor mutations associated with com-bined pituitary hormone deficiency impair the activation of pituitary target genes. Gene 2001; 265: 61–9.
  • Howard PW, Maurer RA. A point mutation in the LIM domain of Lhx3 reduces activation of the glycoprotein hormone a-subunit promoter. J Biol Chem 2001; 276: 19020–6.
  • Sornson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, O'Connell SM, et al. Pituitary lineage determination by the Prophet of Pit1 homeodomain factor defective in Ames dwarfism. Nature 1996; 384: 327–33.
  • Sloop KW, McCutchan Schiller A, Smith TP, Blanton JR Jr, Rohrer GA, Meier BC, et al. Biochemical and genetic characterization of the porcine Prophet of Pit-1 pituitary transcription factor. Mol Cell Endocrinol 2000; 168: 77–87.
  • Showalter AD, Smith TPL, Bennett G, Sloop KW, Whitsett JA, Rhodes Si. Differential conservation of transcriptional domains of mammalian Prophet of Pit-1 proteins revealed by structural studies of the bovine gene and comparative functional analysis of the protein. Gene (in press).
  • Gage PJ, Roller ML, Saunders TL, Scarlett LM, and Camper SA. Anterior pituitary cells defective in the cell autonomous factor, df, undergo cell lineage specification but not expansion. Development 1996; 122: 151–60.
  • Tang K, Bardce A, Gardiner CS, Wagner TE, Yun is. Gonadotropin secretion, synthesis, and gene expression in human growth hormone transgenic mice and in Ames dwarf mice. Endocrinology 1993; 132: 2518–24.
  • Pernasetti F, Toledo SP, Vasilyev VV, Hayashida CY, Cogan JD, Ferrari C, et al. Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAQ in the prophet of Pit1 gene. J Clin Endocrinol Metab 2000; 85: 390–7.
  • Cogan J, Wu W, Phillips JI, Arnhold I, Agapito A, Fofanova 0, et al. The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J Clin Endocrinol Metab 1998; 83: 3346–9.
  • Fliick C, Deladoey J, Rutishauser K, Eblé AE, Marti U, Wu W, et al. Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg -> Cys at codon 120 (R120C). J Clin Endocrinol Metab 1998; 83: 3727–34.
  • Fofanova 0, Takamura N, Kinoshita E, Vorontsov A, Vladimirova V, Dedov I, et al. MR imaging of the pituitary gland in children and young adults with congenital combined pituitary hormone deficiency associated with PROP1 muta-tions. AJR Am J Roentgenol 2000; 174: 555–9.
  • Li S, Crenshaw III EB, Rawson El, Simmons DM, Swanson LW, Rosenfeld MG. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene Pit1. Nature 1990; 347: 528–33.
  • Ikeda Y, Lala DS, Luo X, Kim E, Moisan M-P, Parker KL. Characterization of the mouse FT Z-FI gene, which encodes a key regulator of steroid hydroxylase gene expression. Mol Endocrinol 1993; 7: 852–60.
  • Ingraham HA, Lala DS, Ikeda Y, Luo X, Shen W-H, Nachtigal MW, et al. The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev 1994; 8: 2302–12.
  • Ikeda Y, Luo X, Abbud R, Nilson JH, Parker KL. The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. Mol Endocrinol 1995; 9: 478–86.
  • Luo X, Ikeda Y, Parker KL. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994; 77: 481–90.
  • Bland ML, Jamieson CAM, Akana SF, Bornstein SR, Eisenhofer G, Dallman MF, et al. Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response. Proc Nat Acad Sci USA 2000; 97: 14488–93.
  • Zhao L, Bakke M, Krimkevich Y, Cushman LJ, Parlow AF, Camper SA, et al. Steroidogenic Factor 1 (SF1) is essential for pituitaty gonadotrope function. Development 2000; 128: 147–54.
  • Liu J, Lin C, Gleiberman A, Ohgi KA, Herman T, Huang H-D, et al. Tbx 19, a tissue-selective regulator of POMC gene expression. Proc Nat Acad Sci USA 2001; 98: 8674–9.
  • Wawersik S, Purcell P, Maas RL. Pax6 and the genetic control of early eye development. Results Probl Cell Differ 2000; 31: 15–36.
  • Wallis DE, Roessler E, Hehr U, Nanni L, Wiltshire T, Richieri-Costa A, et al. Mutations in the homeodomain of the human 5IX3 gene cause holoprosencephaly. Nat Genet 1999; 22: 196–8.
  • Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, et al. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 1999; 23: 323–8.
  • Rappold GA, Fukami M, Niesler B, Schiller S, Zumkel-ler W, Bettendorf M, et al. Deletions of the homeobox gene SHOX (Short Stature Homeobox) are an important cause of growth failure in children with short stature. J Clin Endocrinol Metab 2002; 87: 1402–6.
  • Krude H, Biebermann H, Luck W, Horn R, Brabant G, Griiters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998; 19: 155–7.
  • Collu R, Tang J, Castagné J, Lagacé G, Masson N, Huot C, et al. A novel mechanism for isolated central hypothyr-oidism: inactivating mutations in the thyrotropin-releasing hormone receptor gene. J Clin Endocrinol Metab 1997; 82: 1561–5.
  • Dacou-Voutetakis C, Feltquate DM, Drakopoulou M, Kourides IA, Dracopoli NC. Familial hypothyroidism caused by a nonsense mutation in the thyroid-stimulatirg hormone J3-subunitgene. Am J Hum Genet 1990; 46: 988–93.
  • Hayashizaki Y, Hiraoka Y, Endo Y, Matsubara K. Thyroid-stimulatirg hormone (TSH) deficiency caused by a single base substitution in the CAGYC region of the 13-subunit. EMBO J 1989; 8: 2291–6.
  • Bonomi M, Proverbio MC, Weber G, Chiumello G, Beck-Peccoz P, Persani L. Hyperplastic pituitary gland, high serum glycoprotein hormone a-subunit, and variable circulating thyrotropin (TSH) levels as hallmark of central hypothyroid-ism due to mutations of the TSH13 gene. J Clin Endocrinol Metab 2001; 86: 1600–4.
  • Medeiros-Neto G, Herodotou DT, Rajan S, Kommareddi S, de Lacerda L, Sandrini R, et al. A circulating, biologically inactive thyrotropin caused by a mutation in the beta subunit gene. J Clin Invest 1996; 97: 1250–6.
  • Salvatori R, Hayashida CY, Aguiar-Oliveira MH, Phillips 111 JA, Souza AHO, Gondo RG, et al. Familial Dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. J Clin Endocrinol Metab 1999; 84: 917–23.
  • Wajnrajch MP, Gertner JM, Harbison MD, Chua SC Jr, Leibel RL. Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse. Nat Genet 1996; 12: 88–90.
  • Salvatori R, Xiaoguang F, Phillips IR JA, Espigares-Martin R, DE Lara IM, Freeman KL, et al. Three new mutations in the gene for the growth hormone (GH)-releasing hormone receptor in familial isolated GH deficiency type TB. J Clin Endocrinol Metab 2001; 86: 273–9.
  • Human Gene Mutation Database (http://archive.uwcm. ac.uk/uwcm/mg/hgmd0.html).
  • Costa EMF, Bedecarrats GY, Mendonca BB, Arnhold UP, Kaiser UB, Latronico AC. Two novel mutations in the gonadotropin-releasirg with hypogonadotropk hypogonad- ism and normal olfaction J Clin Endocrinol Metab 2001; 86: 2680–6.
  • De Roux N, Young J, Misrahi M, Genet R, Chanson P, Schaison G, et al. A family with hypogonadotropk hypogonadism and mutations in the gonadotropin releasing hormone receptor. N Engl J Med 1997; 337: 1597–602.
  • Caron P, Chauvin S, Christin-Maitre S, Bennet A, Lahlou N, Counis R, et al. Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration J Clin Endocrinol Metab 1999; 84: 990–6.
  • Pralong FP, Gomez F, Castillo E, Cotecchia S, Abuin L, Aubert ML, et al. Complete hypogonadotropk hypogonad-ism associated with a novel inactivating mutation of the gonadotropin-releasirg hormone receptor. J Clin Endocrinol Metab 1999; 84: 3811–6.
  • De Roux N, Young J, Brailly-Tabard S, Misrahi M, Milgrom E, Schaison G. The same molecular defects of the gonadotropin-releasirg hormone receptor determine a variable degree of hypogonadisna in affected kindred. J Clin Endocrinol Metab 1999; 84: 567–72.
  • Layman LC, Cohen DP, Jin M, Xie J, Li Z, Reindollar RH, et al. Mutations in gonadotropin-releasirg hormone receptor gene cause hypogonadotropk hypogonadism Nat Genet 1998; 18: 14–5.
  • Kotder ML, Chauvin S, Lahlou N, Harris CE, Johnston CJ, Lagarde J-P, et al. A new compound heterozygous mutation of the gonadotropin-releasirg hormone receptor (L314X, Q106R) in a woman with complete hypogonado-tropic hypogonadism: chronic estrogen administration am-plifies the gonadotropin defect. J Clin Endocrinol Metab 2000; 85: 3002–8.
  • Layman LC, Lee E-J, Peak DB, Namnoum AB, Vu KV, van Lingen BL, et al. Delayed puberty and hypogonadian caused by mutations in the follicle-stimulatirg hormone I3-subunit gene. N Engl J Med 1997; 337: 607–11.
  • Matthews CH, Borgato S, Beck-Peccoz P, Adams M, Tone Y, Gambino G, et al. Primary amenorrhoea and infertility due to a mutation in the I3-subunit of follicle-stimulating hormone. Nat Genet 1993; 5: 83–6.
  • Lindstedt G, Nystrom E, Matthews C, Ernest I, Janson PO, Chatterjee K. Follitropin (FSH) deficiency in an infertile make due to FSHI3 gene mutation. A syndrome of normal puberty and virilizaticn but underdeveloped testicles with azoospermia, low FSH but high lutropin and normal serum testosterone concentrations. Clin Chem Lab Med 1998; 36: 663–5.
  • Weiss J, Axelrod L, Whitcomb RW, Harris PE, Crowley WF, Jameson JL. Hypogonadisna caused by a single amino acid substituticn in the 13 subunit of luteinizing hormone. N Engl J Med 1992; 326: 179–83.
  • Lin SC, Lin CR, Gukovsky I, Lusis AJ, Sawchenko PE, Rosenfeld MG. Molecular basis of the little mouse pheno-type and implications for cell type-specific growth. Nature 1993; 364: 208–13.
  • Maheshwari HG, Silverman BL, Dupuis J, Baumann G. Phenotype and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor: Dwarfism of Sindh. J Clin Endocrinol Metab 1998; 83: 4065–74.
  • Thenunen APN, Huhtaniemi IT. Mutations of gonadotro-pins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 2000; 21: 551–83.
  • Hinuma S, Habata Y, Fujii R, Kawamata Y, Hosoya M, Fukusumi S, et al. A prolactin-releasing peptide in the brain. Nature 1998; 393: 272–6.
  • Turkington RW. Phenothiazine stimulation test for prolactin reserve: the syndrome of isolated prolactin deficiency. J Clin Endocrinol Metab 1972; 34: 246–9.
  • Kauppila A, Chatelain P, Kirkinen P, Kivinen S, Ruokonen A. Isolated prolactin deficiency in a woman with puerperal alactogenesis. J Clin Endocrinol Metab 1987; 64: 309–12.
  • Falk RJ. Isolated prolactin deficiency: a case report. Feral Steril 1992; 58: 1060–2.
  • Klein C, Brin MF, Kramer P, Sena-Esteves M, de Leon D, Doheny D, et al. Association of a missense change in the D2 dopamine receptor with myoclonus dystonia. Proc Nat! Acad Sci USA 1999; 96: 5173–6.
  • Nothen NM, Cichon S, Hemmer S, Hebebrand J, Remschmidt H, Lehmkuhl G, et al. Human dopamine D4 receptor gene: frequent occurrence of a null allele and observation of homozygosity. Hum Mol Genet 1994; 3: 2207–12.
  • Douglas KR, Camper SA. Partial transcriptome of the developing pituitaxy gland. Genomics 2000; 70: 335–46.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.